Aphro Pharma Private Limited

Pharmaceutical trading company incorporated in 2011 with office in Delhi.

2011 | Delhi (India) | Active
Last Updated:

Aphro Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.30 M
  • Paid Up Capital ₹ 0.30 M
  • Company Age 14 Year, 2 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 0.95 M
  • Revenue Growth -5.32%
  • Profit Growth 77.16%
  • Ebitda -28.99%
  • Net Worth 21.07%
  • Total Assets 19.62%

About Aphro Pharma

Aphro Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 March 2011 and has a history of 14 years and two months. Its registered office is in Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M.

The company currently has active open charges totaling ₹0.95 M.

Mukesh Dhall, Isha Dhall, and Sahil Bathla serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232DL2011PTC216480

  • Company No.

    216480

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    24 Mar 2011

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma
Company report

Aphro Pharma Private Limited

Explore comprehensive data for Aphro Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Aphro Pharma?

Board Members (3)

NameDesignationAppointment DateStatus
Mukesh Dhall Country flag representing In Director 24-Mar-2011Current
Isha Dhall Country flag representing In Director 01-Sep-2014Current
Sahil Bathla Country flag representing In Director 01-May-2016Current

Financial Performance of Aphro Pharma.

Aphro Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.32% decrease. The company also saw a substantial improvement in profitability, with a 77.16% increase in profit. The company's net worth Soared by an impressive increase of 21.07%.

Aphro Pharma revenue growth over time
Aphro Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-5.32%
Revenue from Operations
-5.44%
Total Assets
19.62%
Profit or Loss
77.16%
Net Worth
21.07%
EBITDA
-28.99%

What is the Ownership and Shareholding Structure of Aphro Pharma?

In 2023, Aphro Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0.95 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 0.10 Cr

Latest Charge Details

DateLenderAmountStatus
11 Jan 2024Others₹0.95 MOpen

How Many Employees Work at Aphro Pharma?

Unlock and access historical data on people associated with Aphro Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Aphro Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aphro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aphro Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Aphro Pharma

Recent activity within the organization

  • Charges

    A charge with Others amounted to Rs. 0.95 M with Charge ID 100868390 was registered on 11 Jan 2024.

  • Annual General Meeting

    Aphro Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Aphro Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

  • Director Appointment

    Sahil Bathla was appointed as a Director was appointed as a Director on 01 May 2016 & has been associated with this company since 9 years 1 month .

  • Director Appointment

    Isha Dhall was appointed as a Director was appointed as a Director on 01 Sep 2014 & has been associated with this company since 10 years 9 months .

  • Director Appointment

    Mukesh Dhall was appointed as a Director was appointed as a Director on 24 Mar 2011 & has been associated with this company since 14 years 2 months .

Frequently asked questions

  • What is the Incorporation or founding date of Aphro Pharma Private Limited?

    Aphro Pharma Private Limited was incorporated on 24 Mar 2011.

  • What is authorized share capital and paid-up capital of Aphro Pharma Private Limited?

    The authorized share capital of Aphro Pharma Private Limited is ₹ 0.30 M and paid-up capital is ₹ 0.30 M.

  • Who are the current board members & directors of Aphro Pharma Private Limited?

    Currently 3 directors are associated with Aphro Pharma Private Limited.

    • Mukesh Dhall
    • Isha Dhall
    • Sahil Bathla

  • What is the registered address of Aphro Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Aphro Pharma Private Limited is Shop No - Lg-2 F-27, Madhu Vihar India, Delhi, 110092.

  • What is the corporate identification number (CIN) and company number of Aphro Pharma Private Limited?

    The corporate identification number (CIN) of Aphro Pharma Private Limited is U24232DL2011PTC216480 and the company number is 216480 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Aphro Pharma Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Aphro Pharma Private Limited has fallen by -5.32%.

  • What change has been observed in the net worth of Aphro Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Aphro Pharma Private Limited has experienced an upsurge of 21.07%.

  • What are the total open charges for Aphro Pharma Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Aphro Pharma Private Limited amount to ₹ 0.95 M.

  • When was the last Balance Sheet of Aphro Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Aphro Pharma Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors